Recent studies have shown that elevated HEV/TLS can reduce TNM stage, prolong OS and DFS, and recruit more immune cells, such as CD3+ T cells, CD8+ T cells and M1 macrophages, thereby improving the tumor immune microenvironment [80]. Here, CD8A is linked to neoplasm.